Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Completed 1

Sponsor Class

OTHER 44 OTHER_GOV 2 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 1 Hodgkin Disease 1

Interventions

Radiotherapy 214 Cisplatin 180 Cyclophosphamide 169 Doxorubicin 138 Vincristine 127 Paclitaxel 125 Filgrastim 121 Etoposide 104 Carboplatin 100 Methotrexate 83 Gemcitabine 82 Docetaxel 78 Cytarabine 78 Gene Expression Profiling 74 Fluorouracil 74 Prednisone 71 Granulocyte Colony-Stimulating Factor 66 Dexamethasone 66 Leucovorin 62 Polymerase Chain Reaction 47 Immunohistochemistry 46 Microarray Analysis 40 Daunorubicin 38 Irinotecan 37 Ifosfamide 37 Temozolomide 35 Cetuximab 33 Amplified Fragment Length Polymorphism Analysis 33 Peripheral Blood Stem Cell Transplantation 32 Mercaptopurine 31

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × NETWORK × Positron Emission Tomography Computed Tomography × Clear all

NCT03615664 2025-01-16

BURGUND

Polish Lymphoma Research Group

Phase 2 Completed

Hodgkin Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡